Literature DB >> 7710908

Mechanisms of resistance to topoisomerase inhibitors.

A Y Chen1, L F Liu.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 7710908     DOI: 10.1007/978-1-4615-2632-2_13

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


× No keyword cloud information.
  5 in total

Review 1.  Oral topoisomerase 1 inhibitors in adult patients: present and future.

Authors:  H A Gelderblom; M J DE Jonge; A Sparreboom; J Verweij
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

2.  hsa-miR-9-3p and hsa-miR-9-5p as Post-Transcriptional Modulators of DNA Topoisomerase IIα in Human Leukemia K562 Cells with Acquired Resistance to Etoposide.

Authors:  Evan E Kania; Jessika Carvajal-Moreno; Victor A Hernandez; Anthony English; Jonathan L Papa; Nicholas Shkolnikov; Hatice Gulcin Ozer; Ayse Selen Yilmaz; Jack C Yalowich; Terry S Elton
Journal:  Mol Pharmacol       Date:  2019-12-13       Impact factor: 4.436

3.  Pankiller effect of prolonged exposure to menadione on glioma cells: potentiation by vitamin C.

Authors:  Marina F Vita; Nivedita Nagachar; Dimitrios Avramidis; Zahid M Delwar; Mabel H Cruz; Åke Siden; Kajsa M Paulsson; Juan Sebastian Yakisich
Journal:  Invest New Drugs       Date:  2010-07-13       Impact factor: 3.850

Review 4.  Dual Inhibitors Against Topoisomerases and Histone Deacetylases.

Authors:  Young Ho Seo
Journal:  J Cancer Prev       Date:  2015-06

Review 5.  Functional Genomics Approaches to Elucidate Vulnerabilities of Intrinsic and Acquired Chemotherapy Resistance.

Authors:  Ronay Cetin; Eva Quandt; Manuel Kaulich
Journal:  Cells       Date:  2021-01-28       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.